Welcome to our dedicated page for Churchill Cap X SEC filings (Ticker: CCCXW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Churchill Cap X's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Churchill Cap X's regulatory disclosures and financial reporting.
Infleqtion, Inc. reported that entities associated with sponsor Churchill Sponsor X LLC indirectly acquired 10,650,000 shares of common stock on February 12, 2026 through a conversion of Class B ordinary shares following its business combination with Legacy Infleqtion.
The filing explains that Churchill Capital Corp X was domesticated from the Cayman Islands to Delaware, and its Class B and Class A shares automatically converted into Infleqtion common stock on a one-to-one basis. Churchill Sponsor X LLC now indirectly holds these common shares and 75,000 warrants, while Michael Klein and related entities disclaim beneficial ownership beyond their pecuniary interests.
Infleqtion, Inc. received an updated ownership report from Churchill Sponsor X LLC, M. Klein Associates, Inc., and Michael Klein following the completion of a domestication and merger in mid-February 2026. The group reports beneficial ownership of 10,725,000 Infleqtion common shares, representing 4.9% of the class.
This amount includes 10,650,000 shares of common stock and 75,000 shares underlying private placement warrants, which become exercisable 30 days after completion of the mergers. The filing is labeled as Amendment No. 2 and described as a final, “exit” amendment to their prior Schedule 13D.
Churchill Capital Corp X/Cayman investors Empyrean Capital Partners and Amos Meron report that they no longer own any Class A ordinary shares of the company. In this amended Schedule 13G, they state beneficial ownership of 0 shares, representing 0% of the class, with no voting or dispositive power.
The filing confirms the securities had been held in the ordinary course of business and not for the purpose of changing or influencing control of Churchill Capital Corp X. Both parties certify the accuracy of these disclosures as of the reported ownership date.
Infleqtion, Inc. has completed its business combination with SPAC Churchill Capital Corp X, converting from a Cayman entity into a Delaware corporation and emerging as a publicly traded quantum technology company. Legacy Infleqtion stockholders received an aggregate 151,804,988 shares of common stock, implying a $1.8 billion equity value at a deemed $10.00 per share.
The deal included a PIPE financing in which investors purchased 12,654,760 shares of common stock for $126.5 million. Immediately after closing, the company had 216,471,927 shares outstanding, with Legacy Infleqtion holders owning 70.1%, Churchill public shareholders 19.1%, the sponsor 5.0% and PIPE investors 5.8%.
Churchill’s former shareholders now hold 24.0% of the company, and Churchill ceased to be a shell company. The combined company will trade on the NYSE under the symbols INFQ and INFQ WS, has adopted new charter documents, board committees and compensation plans, and implemented 2026 equity incentive and employee stock purchase plans.
Infleqtion, Inc. (formerly Churchill Capital Corp X) has filed a Form 25 to remove the listing and registration of its securities from The Nasdaq Stock Market LLC under Section 12(b) of the Securities Exchange Act of 1934.
The filing covers the company’s units (each consisting of one Class A ordinary share and one-quarter of one redeemable warrant), its Class A ordinary shares with a par value of $0.0001 per share, and its warrants, where each whole warrant is exercisable for one Class A ordinary share at an exercise price of $11.50. The notification is signed on behalf of the company by Chief Executive Officer Matthew Kinsella.
Churchill Capital Corp X reported that its shareholders overwhelmingly approved its proposed business combination with Infleqtion, Inc., a quantum sensing and quantum computing company. More than 90% of votes cast supported the deal and related proposals at the extraordinary shareholder meeting.
Redemptions were minimal: holders of 37,821 Class A shares, about 0.09% of the class, redeemed for a pro rata $388,453.90, or roughly $10.27 per share. As a result, the transaction is expected to deliver about $551.4 million of gross proceeds to Infleqtion, including approximately $424.8 million from the trust account and $126.5 million from a previously announced private placement.
Churchill will domesticate from the Cayman Islands to Delaware and be renamed Infleqtion, Inc. The combined company’s common stock and warrants are expected to trade on the NYSE under the symbols “INFQ” and “INFQ WS,” with closing of the transaction targeted for February 13, 2026, subject to customary conditions and NYSE listing requirements.
Barclays PLC filed an amended Schedule 13G reporting beneficial ownership of 1,797,424 shares of Churchill Capital Corp X-A common stock, representing 4.31% of the class as of December 31, 2025.
Barclays has sole voting and dispositive power over all reported shares, with no shared power. The firm states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Churchill Capital Corp X-A.
The filing also notes that Barclays’ ownership is 5 percent or less of the company’s common stock, and identifies Barclays Bank PLC and Barclays Capital Inc as relevant subsidiaries.
Churchill Capital Corp X (CCCX) has filed Amendment No. 2 to its Form S-4 to register up to 244,463,410 shares of common stock to be issued in connection with its proposed business combination with ColdQuanta, Inc. (d/b/a Infleqtion). CCCX will domesticate from the Cayman Islands to Delaware and, through a two-step merger, Infleqtion will become a wholly owned subsidiary and the combined public company will be renamed “Infleqtion, Inc.”
The merger values Infleqtion at an aggregate Equity Value of $1,800,000,000, paid entirely in stock at $10.00 per share, implying an estimated exchange ratio of about 0.347 new shares for each Infleqtion common share. A concurrent PIPE Investment will provide $126,547,600 of CCCX common stock at $10.00 per share. Pro forma ownership under no-redemption and maximum-redemption cases ranges from 214,924,762 to 173,524,762 shares outstanding, with Infleqtion holders owning the majority in both scenarios. CCCX’s board unanimously approved the deal, supported by a fairness opinion from Ocean Tomo, and is calling a shareholder meeting on February 12, 2026, while seeking to list the new Infleqtion, Inc. shares on the NYSE under the symbol “INFQ.”
Churchill Capital Corp X has filed an amended Form S-4 for its proposed business combination with quantum technology company ColdQuanta, Inc. (d/b/a Infleqtion). This proxy statement/prospectus covers up to 244,463,410 shares of common stock of the post-closing company to be issued in connection with the merger and related transactions.
The deal values Infleqtion at an equity value of $1.8 billion, to be paid entirely in post-closing common stock at $10.00 per share, with an estimated exchange ratio of about 0.347 post-closing shares for each Infleqtion common share. CCX has also arranged a $126,547,600 PIPE investment at $10.00 per share to help fund the transaction.
Following the deal, CCX will domesticate from the Cayman Islands to Delaware and be renamed Infleqtion, Inc. Pro forma, Infleqtion stockholders are expected to hold the majority of the combined company, with SPAC public holders, the sponsor and PIPE investors owning the balance under various redemption scenarios. The CCX board unanimously approved the merger and received a fairness opinion supporting the purchase price.
Churchill Capital Corp X reporting persons (Churchill Sponsor X LLC, M. Klein Associates, Inc. and Michael Klein) filed Amendment No. 1 to a Schedule 13D reporting beneficial ownership of 10,650,000 ordinary shares, representing 20.4% of the Class A ordinary shares (includes 300,000 Class A and 10,350,000 Class B convertible one-for-one on closing).
The amendment discloses a definitive Merger Agreement to combine Churchill with ColdQuanta, Inc. through a two-step merger and related Transactions, including a $126,547,600 PIPE at $10.00 per share. It also describes an Amended and Restated Registration Rights Agreement with specified resale registration timing, an Amended and Restated Sponsor Agreement with 1,500,000 sponsor shares that vest upon a $12 VWAP trigger or change of control, and an Advisory Agreement paying a $250,000 quarterly retainer to The Klein Group.